Latest On Daré Bioscience, Inc (DARE):
About Daré Bioscience, Inc (DARE):
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The company intends to develop therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single application that completed Phase 3 clinical trials; Ovaprene, a hormone-free, monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone replacement therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214 injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is based in San Diego, California.
General
- Name Daré Bioscience, Inc
- Symbol DARE
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 15
- Last Split Factor1:10
- Last Split Date2017-07-20
- Fiscal Year EndDecember
- IPO Date2014-04-10
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.darebioscience.com
Valuation
- Price/Book (Most Recent Quarter) 131.82
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.14
- Return on Assets -247%
- Return on Equity -10764%
- Earnings Per Share -$1.05
- Revenue Per Share $0
- Gross Profit -533334
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 82.78 million
- EBITDA -13093210
- Analyst Target Price $5.2
- Book Value Per Share $0.02
Share Statistics
- Shares Outstanding 41.6 million
- Shares Float 35.47 million
- % Held by Insiders 830%
- % Held by Institutions 5.89%
- Shares Short 1.2 million
- Shares Short Prior Month 1.43 million
- Short Ratio 0.65
- Short % of Float 3%
- Short % of Shares Outstanding 3%
Technicals
- Beta 1.58
- 52 Week High $3.01
- 52 Week Low $0.78
- 50 Day Moving Average 2.15
- 200 Day Moving Average 1.48
Dividends
- Dividend Date 2017-07-20
- ExDividend Date N/A
- Dividend Yield 0%
Daré Bioscience, Inc (DARE) Dividend Calendar:
DARE's last dividend payment was made to shareholders on July 20, 2017.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Daré Bioscience, Inc (DARE) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-12 | $N/A | -$0.24 | -$0.19 | -29.73% |
2020-06-30 | 2020-08-12 | $N/A | -$0.27 | -$0.17 | -61.97% |
2020-03-31 | 2020-05-14 | $N/A | -$0.18 | -$0.33 | 44.9% |
2019-12-31 | 2020-03-27 | $N/A | -$0.21 | -$0.20 | -7.69% |
2019-09-30 | 2019-11-12 | $N/A | -$0.20 | -$0.20 | 1.23% |
2019-06-30 | 2019-08-14 | $N/A | -$0.29 | -$0.20 | -47.43% |
2019-03-31 | 2019-05-14 | $N/A | -$0.27 | -$0.30 | 10% |
2018-12-31 | 2018-12-31 | $N/A | -$0.25 | -$0.27 | 7.41% |
2018-09-30 | 2018-11-13 | $N/A | -$0.23 | -$0.25 | 6.77% |
2018-06-30 | 2018-08-13 | $N/A | -$0.32 | -$0.24 | -36.17% |
2018-03-31 | 2018-05-14 | $N/A | -$0.88 | ||
2017-12-31 | 2018-03-28 | $1.83 million | -$1.51 | -$3.10 | 51.29% |
2017-09-30 | 2017-11-13 | $-2476000 | -$0.33 | ||
2017-06-30 | 2017-08-14 | $642000 | -$1.42 | ||
2017-03-31 | 2017-05-12 | $1.19 million | -$2.70 | -$3.10 | 12.9% |
2016-12-31 | 2017-03-31 | $766000 | -$1.60 | -$3.35 | 52.24% |
2016-09-30 | 2016-11-03 | $N/A | -$3.60 | -$4.08 | 11.76% |
2016-06-30 | 2016-08-04 | $N/A | -$4.00 | -$4.81 | 16.84% |
2016-03-31 | 2016-05-02 | $N/A | -$4.90 | -$0.43 | -1039.53% |
2015-12-31 | 2016-03-10 | $N/A | -$3.90 | -$0.41 | -851.22% |
2015-09-30 | 2015-11-16 | $N/A | -$0.39 | -$0.41 | 4.88% |
2015-06-30 | 2015-08-06 | $N/A | -$0.37 | -$0.42 | 11.9% |
2015-03-31 | 2015-05-06 | $N/A | -$0.41 | -$0.48 | 14.58% |
2014-12-31 | 2015-03-19 | $80000 | -$0.34 | -$0.49 | 30.61% |
2014-09-30 | 2014-11-13 | $1.64 million | -$0.28 | -$0.40 | 30% |
2014-06-30 | 2014-08-12 | $33000 | -$2.90 | -$3.60 | 19.44% |
2014-03-31 | 2014-05-27 | $47000 | -$37.00 | -$2.97 | -1145.79% |
Daré Bioscience, Inc (DARE) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Daré Bioscience, Inc (DARE) Chart:
Daré Bioscience, Inc (DARE) News:
Below you will find a list of latest news for Daré Bioscience, Inc (DARE) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Daré Bioscience, Inc (DARE) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest DARE Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 5:59 PM EST | 1 | $1.24 |
Jun 13, 2022 6:20 PM EST | 5 | $1.24 |
Jun 13, 2022 7:10 PM EST | 100 | $1.225 |
Jun 13, 2022 7:21 PM EST | 100 | $1.21 |
Jun 13, 2022 7:32 PM EST | 100 | $1.21 |
Daré Bioscience, Inc (DARE) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000098/0001401914-20-000098-index.htm |
2018-09-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1401914/000000000018027798/0000000000-18-027798-index.htm |
2020-05-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1401914/000000000020004042/0000000000-20-004042-index.htm |
2020-05-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1401914/000000000020004649/0000000000-20-004649-index.htm |
2019-01-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1401914/000090266419000189/0000902664-19-000189-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1401914/000110465919008594/0001104659-19-008594-index.htm |
2018-07-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518216324/0001193125-18-216324-index.htm |
2018-08-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1401914/000119312518251659/0001193125-18-251659-index.htm |
2018-08-24 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1401914/000119312518257805/0001193125-18-257805-index.htm |
2018-08-24 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1401914/000119312518257813/0001193125-18-257813-index.htm |
2018-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518258165/0001193125-18-258165-index.htm |
2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518266651/0001193125-18-266651-index.htm |
2018-09-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1401914/000119312518270115/0001193125-18-270115-index.htm |
2018-09-10 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1401914/000119312518270122/0001193125-18-270122-index.htm |
2018-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518275237/0001193125-18-275237-index.htm |
2018-09-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1401914/000119312518278347/0001193125-18-278347-index.htm |
2018-09-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1401914/000119312518278351/0001193125-18-278351-index.htm |
2018-09-25 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1401914/000119312518282604/0001193125-18-282604-index.htm |
2018-09-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000119312518283920/0001193125-18-283920-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518324817/0001193125-18-324817-index.htm |
2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518335165/0001193125-18-335165-index.htm |
2018-11-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518338016/0001193125-18-338016-index.htm |
2018-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518343676/0001193125-18-343676-index.htm |
2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000119312518346148/0001193125-18-346148-index.htm |
2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000119312519039141/0001193125-19-039141-index.htm |
2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000119312519039148/0001193125-19-039148-index.htm |
2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000119312519040784/0001193125-19-040784-index.htm |
2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1401914/000119312520033343/0001193125-20-033343-index.htm |
2019-04-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000119910219000004/0001199102-19-000004-index.htm |
2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118042385/0001209191-18-042385-index.htm |
2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118042386/0001209191-18-042386-index.htm |
2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118042387/0001209191-18-042387-index.htm |
2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118050350/0001209191-18-050350-index.htm |
2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118050351/0001209191-18-050351-index.htm |
2018-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118051266/0001209191-18-051266-index.htm |
2018-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919118051267/0001209191-18-051267-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919119006215/0001209191-19-006215-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000120919119006217/0001209191-19-006217-index.htm |
2019-04-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000125738619000003/0001257386-19-000003-index.htm |
2019-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000125738619000005/0001257386-19-000005-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000125738619000007/0001257386-19-000007-index.htm |
2019-02-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1401914/000139382519000053/0001393825-19-000053-index.htm |
2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000003/0001401914-19-000003-index.htm |
2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000006/0001401914-19-000006-index.htm |
2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000008/0001401914-19-000008-index.htm |
2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000015/0001401914-19-000015-index.htm |
2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000017/0001401914-19-000017-index.htm |
2019-04-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000020/0001401914-19-000020-index.htm |
2019-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000023/0001401914-19-000023-index.htm |
2019-04-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000025/0001401914-19-000025-index.htm |
2019-04-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000027/0001401914-19-000027-index.htm |
2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000029/0001401914-19-000029-index.htm |
2019-04-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000032/0001401914-19-000032-index.htm |
2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000034/0001401914-19-000034-index.htm |
2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000038/0001401914-19-000038-index.htm |
2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000039/0001401914-19-000039-index.htm |
2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000047/0001401914-19-000047-index.htm |
2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000048/0001401914-19-000048-index.htm |
2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000050/0001401914-19-000050-index.htm |
2019-05-31 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000055/0001401914-19-000055-index.htm |
2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000058/0001401914-19-000058-index.htm |
2019-06-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000060/0001401914-19-000060-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000062/0001401914-19-000062-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000064/0001401914-19-000064-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000066/0001401914-19-000066-index.htm |
2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000068/0001401914-19-000068-index.htm |
2019-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000071/0001401914-19-000071-index.htm |
2019-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000074/0001401914-19-000074-index.htm |
2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000080/0001401914-19-000080-index.htm |
2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000081/0001401914-19-000081-index.htm |
2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000084/0001401914-19-000084-index.htm |
2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000086/0001401914-19-000086-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000088/0001401914-19-000088-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000090/0001401914-19-000090-index.htm |
2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000097/0001401914-19-000097-index.htm |
2019-11-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000099/0001401914-19-000099-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000100/0001401914-19-000100-index.htm |
2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000102/0001401914-19-000102-index.htm |
2019-12-06 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000103/0001401914-19-000103-index.htm |
2019-12-09 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000106/0001401914-19-000106-index.htm |
2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191419000109/0001401914-19-000109-index.htm |
2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000003/0001401914-20-000003-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000007/0001401914-20-000007-index.htm |
2020-01-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000009/0001401914-20-000009-index.htm |
2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000012/0001401914-20-000012-index.htm |
2020-01-30 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000014/0001401914-20-000014-index.htm |
2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000018/0001401914-20-000018-index.htm |
2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000020/0001401914-20-000020-index.htm |
2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000022/0001401914-20-000022-index.htm |
2020-02-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000024/0001401914-20-000024-index.htm |
2020-02-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000026/0001401914-20-000026-index.htm |
2020-03-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000028/0001401914-20-000028-index.htm |
2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000032/0001401914-20-000032-index.htm |
2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000034/0001401914-20-000034-index.htm |
2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000036/0001401914-20-000036-index.htm |
2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000038/0001401914-20-000038-index.htm |
2020-03-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000042/0001401914-20-000042-index.htm |
2020-03-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000044/0001401914-20-000044-index.htm |
2020-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000048/0001401914-20-000048-index.htm |
2020-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000050/0001401914-20-000050-index.htm |
2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000052/0001401914-20-000052-index.htm |
2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000054/0001401914-20-000054-index.htm |
2020-05-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000056/0001401914-20-000056-index.htm |
2020-05-01 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000060/0001401914-20-000060-index.htm |
2020-05-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000062/0001401914-20-000062-index.htm |
2020-05-12 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000065/0001401914-20-000065-index.htm |
2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000068/0001401914-20-000068-index.htm |
2020-05-15 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000071/0001401914-20-000071-index.htm |
2020-05-20 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000073/0001401914-20-000073-index.htm |
2020-05-29 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000075/0001401914-20-000075-index.htm |
2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000077/0001401914-20-000077-index.htm |
2020-06-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000079/0001401914-20-000079-index.htm |
2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000081/0001401914-20-000081-index.htm |
2020-06-08 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000083/0001401914-20-000083-index.htm |
2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000085/0001401914-20-000085-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000093/0001401914-20-000093-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000094/0001401914-20-000094-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000095/0001401914-20-000095-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000096/0001401914-20-000096-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000097/0001401914-20-000097-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000098/0001401914-20-000098-index.htm |
2020-07-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000100/0001401914-20-000100-index.htm |
2020-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000105/0001401914-20-000105-index.htm |
2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000109/0001401914-20-000109-index.htm |
2020-09-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000111/0001401914-20-000111-index.htm |
2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000140191420000114/0001401914-20-000114-index.htm |
2020-04-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000149315220005629/0001493152-20-005629-index.htm |
2019-04-16 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000151124119000003/0001511241-19-000003-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000153657419000001/0001536574-19-000001-index.htm |
2018-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000156459018021487/0001564590-18-021487-index.htm |
2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1401914/000156459018029135/0001564590-18-029135-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000156459019000281/0001564590-19-000281-index.htm |
2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1401914/000162828019008388/0001628280-19-008388-index.htm |
2019-04-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1401914/000171157619000003/0001711576-19-000003-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1401914/000173678119000001/0001736781-19-000001-index.htm |
2018-09-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1401914/999999999518002432/9999999995-18-002432-index.htm |
2018-09-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1401914/999999999518002433/9999999995-18-002433-index.htm |
2020-05-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1401914/999999999520001128/9999999995-20-001128-index.htm |
2020-06-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1401914/999999999520001366/9999999995-20-001366-index.htm |
2018-08-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1401914/999999999718007532/9999999997-18-007532-index.htm |
2019-04-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1401914/999999999719002774/9999999997-19-002774-index.htm |
2020-02-10 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1401914/999999999720000615/9999999997-20-000615-index.htm |
2020-03-05 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1401914/999999999720001151/9999999997-20-001151-index.htm |
Daré Bioscience, Inc (DARE) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Daré Bioscience, Inc (DARE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 830%Institutional Ownership: 589%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-04-11 | ROGER HAWLEY | Director | Buy | 454,545.00 | 1.10 | 499,999.50 | 944,956.00 | https://www.sec.gov/Archives/edgar/data/1401914/000125738619000005/0001257386-19-000005-index.htm |